EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents

Hélène Peyrière, Anne Batisse, Nathalie Fouilhé Sam-Laï, Amélie Daveluy iD, Christine Fournier-Choma, Sylvie Deheul, Cécile Chevalier, Clémence Lacroix, Valérie Gibaja, Aurélie Aquizerate, Stéphanie Pain, Emilie Jouanjus iD und 2 weitere

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Hélène Peyrière und 13 weiteren Autor:innen. Beteiligte Einrichtung: Addictovigilance Centre, Montpellier University Hospital, France. Hauptthemen laut MEDLINE: Psychotropic Drugs, Pharmacovigilance, Substance-Related Disorders. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MILDECA (Mission Interministérielle de Lutte contre les Conduites Addictives), Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents.

Methods

Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotropic DrugsPharmacovigilanceSubstance-Related DisordersHumansAdolescentMaleChildFemaleFranceDatabases, FactualCannabinoidsAdverse Drug Reaction Reporting Systems

Stichwörter der Autor:innen

Addictovigilanceadolescentschildrenclustersdeathpsychoactive substances

Substanzen

Psychotropic DrugsCannabinoids

Autor:innen und Institutionen

  • Addictovigilance Centre, Montpellier University Hospital, France.
  • INSERM U 1058, Pathogenesis and Control of Chronic Infections (PCCI), Montpellier, France.
  • Addictovigilance Centre, AP-HP (Paris Public Hospitals), Paris, France.
  • Addictovigilance Centre, Grenoble-Alpes University Hospital, France.
  • Addictovigilance Centre, Bordeaux University Hospital, France.
  • Addictovigilance Centre, Clermont-Ferrand University Hospital, France.

ORCID-Profile: Amélie Daveluy, Emilie Jouanjus

Förderung

  • MILDECA (Mission Interministérielle de Lutte contre les Conduites Addictives)
  • Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives

Zitieren

APA

Peyrière, H., Batisse, A., Sam-Laï, N. F., Daveluy, A., Fournier-Choma, C., Deheul, S., Chevalier, C., Lacroix, C., Gibaja, V., Aquizerate, A., Pain, S., Jouanjus, E., Picot, M. C., & Nogue, E. (2025). Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70133

Vancouver

Peyrière H, Batisse A, Sam-Laï NF, Daveluy A, Fournier-Choma C, Deheul S, et al. Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70133

BibTeX
@article{Peyrire2025,
  author = {Peyrière, Hélène and Batisse, Anne and Sam-Laï, Nathalie Fouilhé and Daveluy, Amélie and Fournier-Choma, Christine and Deheul, Sylvie and Chevalier, Cécile and Lacroix, Clémence and Gibaja, Valérie and Aquizerate, Aurélie and Pain, Stéphanie and Jouanjus, Emilie and Picot, Marie-Christine and Nogue, Erika},
  title = {Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70133}
}
Kostenlos starten →